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Viruses are adept at evolving or co-opting genomic elements that allow them to maximize their 
replication potential in the infected host. This evolutionary plasticity makes viruses an invalu-
able system to identify new mechanisms used not only by viruses but also by vertebrate cells to 
modulate gene expression. Here, I discuss the identification and characterization of viral mRNA 
structures and noncoding RNAs that have led to important insights into the molecular mechanisms 
of eukaryotic cells.Viruses have historically represented a 
valuable experimental system to study 
the molecular biology of mammalian 
cells. In part, this is due to the fact that, 
prior to the advent of RNA interference, 
viruses represented the most genetically 
tractable system available to study how 
mammalian cells function. Moreover, 
because many viruses express their 
genomes, mRNAs, and proteins at very 
high levels, it proved pos-
sible to perform biochemical 
and molecular experiments 
using viral gene products 
that were difficult to attempt 
using cellular gene products. 
As a result, virus research led 
to the initial identification of 
almost all of the known post-
transcriptional modifications 
of mRNA transcripts. These 
include mRNA capping, first 
discovered by analysis of 
reovirus and vaccinia virus 
mRNAs (Furuichi et al., 1975; 
Wei and Moss, 1975); mRNA 
splicing, first discovered by 
analysis of adenovirus tran-
scripts (Berget et al., 1977; 
Chow et al., 1977); and poly-
adenylation, first described 
for vaccinia virus mRNAs 
(Kates, 1970). In addition, 
mutational analysis has also 
identified several structures 
located in viral mRNA mol-
ecules that play key roles in 
their transcription, nuclear 
export, or translation (Table 1, 
Figure 1). Finally, many viruses 
express a number of noncod-
ing RNAs that enhance viral replication 
and pathogenesis but whose functions 
and mechanisms of action often remain 
poorly understood.
TAR RNA and HIV-1 Transcription
Although viral RNA elements obviously 
play an important role in directing the 
transcription of the genomes and anti-
genomes of RNA viruses, the transacti-
vation response (TAR) element remains 
unique in that it promotes the efficient 
transcription of human immunodefi-
ciency virus type 1 (HIV-1) proviral DNA 
by cellular RNA polymerase II (RNAP II). 
HIV-1 is a complex retrovirus, that is, it 
encodes not only the canonical struc-
tural proteins and enzymes found in all 
retroviruses (Gag, Pol, and Env) but also 
four auxiliary proteins and two regula-
tory proteins, Tat and Rev. 
Mutational analysis of HIV-1 
mutants lacking a functional 
tat gene showed that these 
were replication defective 
due to a dramatic drop in 
transcription from the long 
terminal repeat (LTR) pro-
moter element (Fisher et al., 
1986; Kao et al., 1987). Sub-
sequent analysis mapped the 
target site for the Tat protein 
to a ~50 base pair (bp) ele-
ment located immediately 3′ 
to the transcription start site. 
TAR folds into a simple RNA 
stem-loop structure that rep-
resents the actual target for 
Tat function (Feng and Hol-
land, 1988).
It is now known that Tat first 
interacts with a cellular factor 
called cyclin T1, which, along 
with the kinase cdk9, consti-
tutes positive transcription 
elongation factor b (P-TEFb) 
(Wei et al., 1998). The resulting 
complex of Tat and P-TEPb 
binds directly to HIV-1 TAR via 
the terminal loop and an adja-
cent RNA bulge. Once bound 
Figure 1. Viral Noncoding RNAs or RNA Structures Influence 
 Eukaryotic Gene Expression
The HIV-1 Tat protein activates transcription of the HIV-1 provirus by recruiting 
the cellular P-TEFb complex to the viral TAR RNA hairpin. Nuclear export of 
incompletely spliced HIV-1 transcripts is facilitated by the RRE RNA structure, 
which recruits a complex consisting of the viral Rev protein and cellular CRM1. 
A similar function is performed by the CTE RNA structure present in MPMV, 
which recruits the cellular Tap nuclear export factor. The cytoplasmic transla-
tion of picornaviral mRNAs is facilitated by IRES elements, and the transla-
tion of retroviral and coronaviral mRNAs is modulated by sequences that in-
duce ribosomal frameshifting. Finally, the translation of both viral and cellular 
mRNAs can be specifically downregulated by virally encoded  microRNAs.592 Cell 136, February 20, 2009 ©2009 Elsevier Inc.
Table 1. Important Viral mRNA Structures
Name Virus Family Function
Transactivation response  
(TAR) element
HIV-1 and other lentiviruses Binds to a complex containing viral Tat and cellular P-TEFb to activate 
transcription elongation
Rev response element  
(RRE)
Lentiviruses; analogous structures found  
in δ-retroviruses 
Recruits a complex of viral Rev and cellular CRM1 to induce nuclear 
export of incompletely spliced viral mRNAs
Constitutive transport  
element (CTE)
MPMV and some other simple  
retroviruses
Recruits the cellular Tap/p15 complex to induce nuclear export of 
incompletely spliced viral mRNAs
Internal ribosome entry  
site (IRES)
Picornaviruses and some flaviviruses Recruits cellular translation factors and ribosomal subunits to viral 
translation initiation codons in the absence of an mRNA capto TAR, P-TEFb mediates the phosphory-
lation of negative regulators of transcrip-
tion elongation and of the carboxy-ter-
minal domain of RNAP II molecules that 
have initiated transcription of HIV-1 pro-
viral DNA. These phosphorylation events 
render RNAP II elongation competent 
and allow it to transcribe the entire viral 
genome (Barboric and Peterlin, 2005; Kao 
et al., 1987). In contrast, in the absence of 
Tat or TAR, transcription initiation at the 
LTR promoter still occurs but almost all 
of these initiating RNAP II molecules fall 
off the DNA template within ~200 bp of 
the transcription start site. Analysis of Tat 
function led to the realization that not only 
transcription initiation but also transcrip-
tion elongation can regulate gene expres-
sion levels in animal cells (Barboric and 
Peterlin, 2005).
Retroviral Nuclear mRNA Export
Almost all retroviruses contain a single 
RNAP II-dependent promoter element in 
the viral LTR that drives transcription of an 
initial genome-length RNA that also acts 
as an mRNA for translation of the viral Gag 
and Pol proteins (Cullen, 2003). In the case 
of HIV-1, this initial transcript can also be 
processed into fully spliced transcripts 
encoding the Tat and Rev proteins of HIV-1 
as well as the auxiliary protein Nef. Alter-
natively, this transcript can be processed 
into partially spliced mRNAs encoding the 
three other viral auxiliary proteins Vif, Vpu, 
and Vpr. The HIV-1 replication cycle, there-
fore, requires that the single initial viral 
transcript is exported out of the nucleus in 
several differentially spliced forms. These 
include an unspliced form that programs 
Gag and Pol expression and that is pack-
aged into virion progeny; partially spliced 
forms that program expression of Env, Vif, 
Vpr, and Vpu; and fully spliced forms that 
program expression of Tat, Rev, and Nef 
(Cullen, 2003).The difficulty with this scenario is that 
eukaryotic cells do not normally permit 
the nuclear export of intron-containing 
mRNAs. Almost all cellular mRNAs are 
transcribed as intron-containing pre-
mRNAs, and these introns are recog-
nized in the nascent transcript by splicing 
factors, including commitment factors. 
Commitment factors both commit the 
pre-mRNA to the splicing pathway and 
retain the pre-mRNA in the nucleus until 
all introns are removed (Legrain and 
Rosbash, 1989).
HIV-1 mRNAs rely entirely on cellu-
lar factors for appropriate splicing, and 
intron-containing HIV-1 transcripts are 
therefore also retained in the infected 
cell nucleus by splicing commitment 
factors. The strategy that HIV-1 has 
evolved to circumvent this nuclear 
retention is dependent on the viral Rev 
protein, which is translated from a fully 
spliced viral mRNA that is constitutively 
exported from the nucleus. As a result, 
HIV-1 mutants lacking a functional rev 
gene are able to express the proteins 
encoded by fully spliced viral mRNAs, 
that is, Tat, Nef, and the defective Rev 
protein itself, but cannot express any of 
the proteins encoded by incompletely 
spliced viral mRNAs, including Gag, 
Pol, and Env. The transcripts encoding 
these viral structural proteins, however, 
can be detected in the nucleus of cells 
infected by Rev-deficient viruses, where 
they are either degraded or eventually 
fully spliced and then exported (Cullen, 
2003).
Rev function requires a highly struc-
tured RNA target, located in the HIV-1 env 
gene, called the Rev response element or 
RRE (Malim et al., 1989). The RRE contains 
a single, high-affinity Rev-binding site and 
also functions as a scaffold for the multi-
merization of Rev on viral mRNAs. Rev in 
turn interacts with a cellular factor called Cell 136,CRM1 that belongs to the karyopherin 
family of nucleocytoplasmic transport pro-
teins (Fischer et al., 1995). This interaction 
is mediated by a leucine-rich motif located 
toward the carboxyl terminus of Rev that 
was the first nuclear export signal (NES) 
to be identified and is the prototype of the 
leucine-rich class of NESs.
Karyopherin function is regulated by 
the action of a G protein called Ran, 
which, like all G proteins, is active when 
bound by GTP and inactive when bound 
by GDP (Kohler and Hurt, 2007). Cells 
contain high levels of a Ran-specific G 
nucleotide exchange factor (GEF) in the 
nucleus and of a Ran-specific GTPase 
activating protein (GAP) in the cytoplasm. 
As a result, Ran:GTP is largely nuclear 
and Ran:GDP is mainly cytoplasmic. 
Ran:GTP binds to CRM1 in the nucleus 
and activates the binding of CRM1 to 
leucine-rich NESs. The ribonucleoprotein 
complex, consisting of Ran:GTP, CRM1, 
and Rev, that forms on the HIV-1 RRE 
directs incompletely spliced HIV-1 tran-
scripts to the nuclear pore complex and 
then into the cytoplasm, where hydro-
lysis of the GTP moiety by cytoplasmic 
GAP disassembles this complex.
Although Rev was the first nuclear 
mRNA export factor to be identified, 
it soon became clear that CRM1 is 
not required for the nuclear export of 
most cellular mRNAs. In fact, CRM1 is 
involved largely in the nuclear export of 
small nuclear RNAs (snRNAs) and pre-
ribosomal subunits, as well as in protein 
nuclear export (Kohler and Hurt, 2007). 
So which factors are required for the 
export of cellular mRNAs?
An important part of the answer 
emerged from analysis of a second 
retrovirus called Mason-Pfizer mon-
key virus (MPMV). MPMV has a simpler 
genomic organization than HIV-1 and 
only encodes the three structural proteins  February 20, 2009 ©2009 Elsevier Inc. 593
Gag, Pol, and Env. Nevertheless, MPMV 
expresses both a genome-length Gag/
Pol mRNA and a spliced Env mRNA. As 
MPMV does not encode a Rev homolog, 
how do the incompletely spliced genomic 
MPMV mRNAs reach the cytoplasm? This 
question led to the discovery of an RNA 
stem-loop structure within the MPMV 
genome, the constitutive transport ele-
ment (CTE), that mediates the nuclear 
export of incompletely spliced mRNAs in 
the absence of any viral proteins (Bray et 
al., 1994). Further analysis revealed that 
the CTE recruits a heterodimer of two cel-
lular proteins, Tap and p15, that also plays 
a critical role in the nuclear export of the 
majority of cellular mRNAs (Grüter et al., 
1988; Kohler and Hurt, 2007). Normally, 
the Tap/p15 heterodimer is only recruited 
to mature, fully spliced mRNAs. However, 
the CTE is able to prematurely recruit 
Tap/p15 to partially spliced mRNAs and 
thereby circumvents the nuclear retention 
of incompletely spliced MPMV mRNAs. 
Although CTEs have now been defined in 
several other exogenous and endogenous 
retroviruses, not all CTEs act by directly 
recruiting Tap/p15. In particular, the avian 
leukemia virus CTE does not appear to 
bind to Tap or p15 directly, although Tap 
may be required for its function (LeBlanc 
et al., 2007). Further analysis may reveal 
new insights into how the export of retro-
viral nuclear mRNAs is regulated.
Viral mRNA Translation, IRES 
Elements, and Frameshifting
After an mRNA is exported to the cyto-
plasm, it must recruit cellular ribosomes 
in order for the translation of the encoded 
open reading frame to occur (Figure 1). 
The process of translation initiation is 
both complex and heavily regulated. For 
the majority of cellular mRNAs, it is initi-
ated by the recruitment of the eukaryotic 
initiation factor eIF4F to the mRNA 5′ cap 
(Martinez-Salas et al., 2008) (see Review 
by N. Sonenberg and A.G. Hinnebusch 
in this issue of Cell). eIF4F consists of the 
cap-binding protein eIF4E, the RNA heli-
case eIF4A, and a third protein, eIF4G. 
The role of eIF4G is to facilitate recruit-
ment of the 43S preinitiation complex, 
consisting of the 40S ribosomal sub-
unit, found in a complex with the initiator 
methionine tRNA (Met-tRNAi) and other 
eIFs, to the mRNA cap. Once recruited 
to the cap, the 40S subunit then scans 594 Cell 136, February 20, 2009 ©2009 Elsealong the mRNA searching for the trans-
lation initiation codon. At this point, the 
60S ribosomal subunit is also recruited 
and translation initiation occurs (Marti-
nez-Salas et al., 2008).
Picornaviruses presented two mys-
teries in terms of how these pathogenic 
viruses are able to translate the single 
large polyprotein encoded by their posi-
tive-sense RNA genome. First, the single 
genome-length picornavirus mRNA is 
uncapped. Second, infection by picor-
naviruses such as poliovirus results in 
the efficient translation of viral mRNAs, 
yet cellular mRNA translation is largely 
blocked. So, why is this uncapped viral 
mRNA translated more efficiently than 
capped cellular mRNAs?
The key discovery that led to the reso-
lution of this conundrum was the identifi-
cation of the poliovirus internal ribosome 
entry site (IRES), a ~450 nucleotide (nt) 
highly structured RNA element found 
in the 5′ untranslated region (5′UTR) of 
poliovirus mRNAs (Jang et al., 1988; Pel-
letier and Sonenberg, 1988). The IRES 
directly recruits several eIFs and the 
40S ribosomal subunit to an internal 
viral translation initiation codon without 
the requirement for either cap binding or 
5′UTR scanning. As a result, poliovirus 
translation is independent of the host 
cell cap recognition factor eIF4E. More-
over, although poliovirus translation ini-
tiation does require eIF4G, it functions 
perfectly well with the carboxy-terminal 
fragment of eIF4G that is generated by 
the proteolytic cleavage of eIF4G by a 
virus-encoded protease. Because cap-
dependent translation requires full-
length eIF4G, this cleavage blocks host 
cell translation, whereas viral mRNA 
translation is not only unimpeded but in 
fact is enhanced by the access of viral 
mRNAs to the entire pool of available 
eIFs and ribosomal subunits (Martinez-
Salas et al., 2008).
Subsequent work has demonstrated 
that all picornaviruses as well as some 
flaviviruses, including hepatitis C virus 
(HCV), contain IRES elements. Surpris-
ingly, these exist in several functionally 
distinct classes. For example, the HCV 
IRES, unlike the poliovirus IRES, can 
directly recruit 40S ribosomal subunits 
to the viral internal translation initiation 
codon in the absence of eIFs, although 
eIFs do participate in the process of vier Inc.translation initiation (Martinez-Salas et 
al., 2008). An even more unusual IRES is 
found in cricket paralysis virus (CrPV), a 
picornavirus-like insect virus (Jan et al., 
2003; Pestova and Hellen, 2003). The 
CrPV IRES not only is able to recruit both 
the 40S and 60S ribosomal subunits to 
assemble elongation-competent 80S 
ribosomes on viral mRNAs but also acts 
as a mimic of Met-tRNAi to permit initia-
tion of the translation of viral capsid pro-
teins in the absence of Met-tRNAi.
Although IRES elements were first 
discovered in RNA viruses, a subset of 
cellular mRNAs are now known to also 
contain IRESs. Interestingly, IRESs seem 
to be especially prevalent in mRNAs 
whose expression is activated by stress, 
when cap-dependent translation may be 
inefficient. Many IRES-containing host 
mRNAs encode proteins that protect 
cells from stress, whereas the proteins 
encoded by other IRES-containing cellu-
lar mRNAs seem to be important during 
apoptosis (Bushell et al., 2006; Komar 
and Hatzoglou, 2005).
Another interesting translational phe-
nomenon observed in several virus 
families, including many species of 
retroviruses and all coronaviruses, is 
programmed ribosomal frameshifting 
(Brierley and Dos Ramos, 2006). In ret-
roviruses such as HIV-1, frameshifting 
prevents some ribosomes from termi-
nating translation at the end of the open 
reading frame (ORF) encoding the Gag 
structural protein and instead induces 
ribosomes to shift into the overlapping 
pol ORF, resulting in the production of 
the large Gag-Pol polyprotein. Similarly, 
in coronaviruses, ribosomal frameshift-
ing is used to produce the 1a/1b repli-
case polyprotein rather than the shorter 
1a variant. Frameshifting is induced by 
a bipartite element consisting of a 5′ 
frameshifting site and an adjacent 3′ 
RNA structure (Brierley and Dos Ramos, 
2006; Jacks et al., 1988). The frame-
shift site has the consensus sequence 
X_XXY_YYZ (where the translational 
phase is indicated), which then slips 
into the −1 frame, that is, XXX_YYY_Z. 
The actual shift sites found in HIV-1 and 
the SARS coronavirus are U_UUU_UUA 
and U_UUA_AAC, respectively. The 3′ 
RNA structure found in HIV-1 is thought 
to be a simple RNA hairpin but other −1 
frameshifting signals instead contain a 
pseudoknot 3′ to the frameshift signal 
(Brierley and Dos Ramos, 2006). It has 
been proposed that the function of the 
3′ RNA structure is to induce transient 
ribosomal pausing at the frameshift site 
to facilitate ribosomal slippage in the −1 
direction. Although frameshifting in HIV-1 
occurs with an efficiency of ~5%, frame-
shifting efficiency in other viruses can 
be as high as ~25% and may be facili-
tated by a direct interaction between the 
paused ribosome and the downstream 
pseudoknot structure. Programmed 
frameshifting is not unique to viruses but 
is found also in a small number of cellular 
genes in both eukaryotes and bacteria 
(Shigemoto et al., 2001; Tsuchihashi and 
Kornberg, 1990).
Viruses, RNA Interference, and 
MicroRNAs
RNA interference (RNAi) was first discov-
ered by genetic analysis in nematodes 
(Fire et al., 1998); however, it is likely that 
RNAi first evolved as an innate immune 
response to viral infection. Indeed, RNAi 
continues to represent a key component 
of the antiviral response in plants and 
invertebrates (Cullen, 2006). The triggers 
for RNAi in these species are the long 
double-stranded RNAs (dsRNAs) that 
form critical intermediates in the repli-
cation of all RNA viruses except retrovi-
ruses. These dsRNAs are bound by the 
RNase III-related enzyme Dicer, which 
progressively cleaves these dsRNAs into 
~22 bp RNA duplexes containing ter-
minal 2 nt 3′ overhangs (see Review by 
R.W. Carthew and E.J. Sontheimer in this 
issue of Cell). One strand of this duplex, 
called a small-interfering RNA (siRNA), is 
then incorporated into the RNA-induced 
silencing complex (RISC), where it acts 
as a guide for RNA to target RISC to 
complementary regions of viral genomic, 
anti-genomic, or mRNA species. RISC 
then cleaves these viral RNAs, leading 
to their degradation. The first siRNAs to 
be identified were in fact antiviral siRNAs 
produced in tobacco cells infected by 
a pathogenic RNA virus, potato virus X 
(Hamilton and Baulcombe, 1999).
RNAi is a critical component of the 
antiviral immune response in plants and 
invertebrates, but emerging evidence 
indicates that RNAi responses to viral 
infection are not induced in mammalian 
somatic cells (Cullen, 2006). Instead, 
mammalian cells have evolved other 
innate responses that are induced by 
viral dsRNAs, including the interferon 
response. Because of the importance 
of RNAi as an antiviral defense in plants 
and insects, many RNA viruses that 
infect these species have evolved gene 
products that inhibit RNAi and, hence, 
enhance virus replication. Conversely, 
the absence of antiviral RNAi responses 
in mammalian cells means that the 
RNAi machinery in these cells generally 
remains active during viral infection (Fig-
ure 1).
Although the role of RNAi as an antivi-
ral response appears to have been lost 
in mammalian somatic cells, the resid-
ual RNAi machinery still plays a very 
important role by mediating the func-
tion of cellular microRNAs (miRNAs). 
Unlike siRNAs, which are derived from 
long dsRNAs (frequently of exogenous 
origin), miRNAs are encoded within the 
cell’s genome as part of one arm of an 
~80 nt RNA hairpin located in a larger 
RNAP II transcript called a primary 
miRNA (Bartel, 2004). After excision, 
by the sequential action of the host cell 
RNase III-related enzymes Drosha and 
Dicer, miRNAs are loaded into RISC and 
downregulate the expression of cellular 
mRNAs. Unlike viral mRNA targets of 
viral siRNAs, cellular mRNAs are rarely 
fully complementary to cellular miRNAs. 
Table 2. Selected Viral Noncoding RNAs
Name Virus Size Function
LAT intron HSV-1 ~2 kb Unclear, but may modulate translation in latently 
infected neurons
PAN KSHV ~1.1 kb Unclear, but contains an element that stabilizes un-
spliced transcripts 
β2.7 hCMV ~2.7 kb Binds to mitochondrial enzyme complex I to stabilize 
ATP production and inhibit apoptosis
VA1 adenovirus ~160 nt Binds to cellular PKR to block PKR activation by viral 
dsRNA and the resultant inhibition in translationCell 136,As full complementarity is a prerequi-
site for efficient cleavage by RISC, cel-
lular mRNAs are generally not subject to 
degradation by cellular miRNAs. Instead, 
cellular miRNAs can induce the transla-
tional inhibition of cellular mRNAs by 
binding to partially complementary tar-
get sites (Bartel, 2004).
As most mammalian viruses do not 
seem to interfere with the loading or 
function of RISC, miRNAs remain active 
in infected cells, thus offering the possi-
bility for viruses to use the cellular RNAi 
machinery to regulate cellular or viral 
gene expression by programming RISC 
with viral miRNAs. Analysis of a range 
of virally infected cells has revealed that 
several DNA viruses, including herpesvi-
ruses, encode multiple distinct miRNAs. 
Of note, most viral miRNAs appear to 
be processed by the same Drosha and 
Dicer dependent pathway used by the 
majority of cellular miRNAs, although 
there are a few examples of viral miRNAs 
that are transcribed by RNA polymerase 
III, not RNAP II, and then excised directly 
by Dicer (Gottwein and Cullen, 2008). 
Similarly, RISCs programmed by viral 
miRNAs appear to function in the same 
way as RISCs programmed by cellular 
miRNAs.
Although beyond the scope of this 
article, it is interesting to note that sev-
eral cellular and viral mRNA targets of 
viral miRNAs have now been defined 
(Gottwein and Cullen, 2008). In gen-
eral, it appears that viral miRNAs either 
downregulate cellular or viral genes that 
increase the sensitivity of virally infected 
cells to host innate or adaptive immune 
responses or, in the case of herpesvirus 
miRNAs, stabilize viral latency by down-
regulating the expression of the viral 
immediate early proteins, which favor 
entry into the lytic replication cycle.
Viral Noncoding RNAs
In addition to miRNAs, a number of DNA 
viruses also encode long noncoding 
RNAs that play a role in regulating viral 
replication and pathogenesis (Table 2; 
reviewed in Sullivan and Cullen, 2009; 
see Review by C.P. Ponting, P.L. Oliver, 
and W. Reik in this issue of Cell). But how 
do viruses use noncoding RNAs to pro-
mote their replication? One interesting 
noncoding RNA is the latency associated  February 20, 2009 ©2009 Elsevier Inc. 595
transcript (LAT) encoded by herpes sim-
plex virus type 1 (HSV-1). LAT is an ~8.3 
kb capped polyadenylated RNA that is 
the only viral RNA expressed at high 
levels in neurons latently infected with 
HSV-1. LAT is spliced to give an unstable 
~6.3 kb exonic RNA and a stable ~2 kb 
intron. The instability of the 6.3 kb LAT 
RNA appears to be due to the fact that 
it is processed into several viral miRNAs 
that may play a key role in regulating 
HSV-1 latency (Umbach et al., 2008). The 
role of the stable 2 kb LAT intron is less 
clear, but evidence has been presented 
arguing that the LAT intron is exported 
out of the nucleus by CRM1 and asso-
ciates with cellular ribosomes, thus 
suggesting a role in modulating mRNA 
translation in neurons latently infected 
with HSV-1 (Atanasiu and Fraser, 2007).
Another interesting viral noncoding 
RNA is the polyadenylated nuclear (PAN) 
RNA encoded by Kaposi’s sarcoma-
associated herpesvirus (KSHV). PAN is 
an unspliced RNAP II transcript that is 
the most highly expressed viral RNA dur-
ing lytic KSHV infection, comprising up 
to 80% of all viral RNAs. Remarkably, the 
function of this RNA in the viral life cycle 
is still unclear. However, recent data 
demonstrate that PAN contains a novel 
~80 nt-long RNA element that stabilizes 
PAN RNA in the infected cell nucleus. 
Insertion of this viral RNA element in cis 
also increases the nuclear abundance 
of cellular mRNAs, such as β-globin 
mRNAs, that are normally unstable when 
expressed in an intronless form (Conrad 
et al., 2006). It is unclear whether this 
element simply stabilizes PAN RNAs or 
whether it also acts in trans to stabilize 
other KSHV-coding mRNAs, which are 
also largely intronless.
Finally, several viral noncoding RNAs 
seem to be inhibitors of cellular innate 
antiviral immune responses. For exam-
ple, the β2.7 noncoding RNA encoded by 
human cytomegalovirus (hCMV) binds to 
mitochondrial enzyme complex I of the 
host cell. This interaction stabilizes the 
production of ATP in infected cells and 
also inhibits virally induced apoptosis 
(Reeves et al., 2007). Another noncoding 
RNA, the VA1 RNA expressed by adeno-
virus, also binds to a cellular factor to 
inhibit an antiviral response. In this case, 
the target is protein kinase R (PKR), a 
cellular protein that binds to the long 596 Cell 136, February 20, 2009 ©2009 ElsedsRNAs produced by adenoviruses and 
many other pathogenic viruses. Binding 
of dsRNA by PKR induces PKR dimeriza-
tion and autophosphorylation as well as 
phosphorylation of cellular eIF2α, which 
results in a global inhibition of translation 
in the infected host cell. VA1, a highly 
structured ~160 nt-long noncoding 
RNA, binds to PKR with high affinity and 
blocks PKR dimerization and activation. 
This prevents the inhibition of translation 
induced by adenovirus-derived dsRNAs 
and allows virus replication to proceed 
unimpeded (Mathews and Shenk, 1991). 
Interestingly, both hCMV β2.7 and ade-
novirus VA1, like KSHV PAN and HSV-1 
LAT, are also expressed at high levels in 
infected cells. β2.7 comprises up to 20% 
of all viral transcripts in hCMV-infected 
cells, and adenovirus VA1 is expressed 
at an extraordinarily high number of cop-
ies (~108) per infected cell. Presumably, 
these high expression levels facilitate 
the saturation of cellular binding sites for 
these RNAs.
Conclusion
Efforts to understand the replication 
cycles of viruses are often motivated by 
the pathogenic potential of these intra-
cellular parasites. However, such analy-
ses have also led to several key insights 
into how not only infected cells but also 
uninfected cells regulate the expression 
of their genome. Moreover, as noted 
in the brief discussion of viral noncod-
ing RNAs, our knowledge of how virally 
encoded transcripts work in the host 
cell remains far from complete. Clearly, 
future research into virus replication will 
provide unexpected and exciting insights 
into the complex molecular machinery 
that makes human cells tick. 
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